OpenVSafe by OpenVAERS
Search V-safe

46M-12269-59278

3 vaccinations 3 coded responses 24 check-ins 3 free-text entries 1 call case
Sex
Male
Age at first dose
0-4
ZIP prefix
900 / CA
Registered
2022-06-20
Relationship
Child or adolescent in my care
Guardian
5ET-20245-26776
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-20
    Registered in v-safe
  2. 2022-09-07
    Dose 1 — Moderna
  3. 2022-09-08
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Vomiting
    Under 3 check-in
  4. 2022-09-09
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Vomiting
    Under 3 check-in
  5. 2022-09-10
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-09-11
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Vomiting
    Under 3 check-in
  7. 2022-09-12
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-09-13
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-09-14
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-09-21
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  11. 2022-09-28
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-10-05
    Dose 2 — Moderna
    Co-administered: Flu
  13. 2022-10-05
    Health check-in — day 0, dose 2, under 3
    Feeling: Good · Irritability/crying
    Under 3 check-in
  14. 2022-10-06
    Survey response — days 1–6 daily, dose 2, under 3
    MedDRA: Constipation — Feeling: Good · Fever
    Free text: Possibly dehydrated and constipated
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-10-07
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  16. 2022-10-08
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  17. 2022-10-09
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  18. 2022-10-10
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  19. 2022-10-11
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  20. 2022-10-12
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  21. 2022-10-21
    Survey response — day 14, dose 2, under 3
    MedDRA: Nasopharyngitis, Pyrexia, Rhinorrhoea — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Common cold symptoms of runny nose and fever
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-10-21
    Report sent to call center — day 14, dose 2, under 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  23. 2022-10-24
  24. 2022-10-26
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  25. 2022-11-02
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  26. 2022-11-09
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  27. 2022-11-16
    Survey response — day 42, dose 2, under 3
    MedDRA: Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school
    Free text: Upper respiratory infection
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-12-30
    Dose 3 — Moderna
  29. 2023-01-04
    Health check-in — 3 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  30. 2023-03-31
    Health check-in — 3 months, dose 3, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-09-07Moderna No
22022-10-05Moderna Flu
32022-12-30Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2022-10-21 Unsuccessful

Free text

Release 12 (Under 3) — days 1–6 daily, dose 2, under 3

2022-10-06

Systemic reaction (other): Possibly dehydrated and constipated

Release 12 (Under 3) — day 14, dose 2, under 3

2022-10-21

Symptoms: Common cold symptoms of runny nose and fever

Release 12 (Under 3) — day 42, dose 2, under 3

2022-11-16

Symptoms: Upper respiratory infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓
SDPyrexia · · ✓
SDRhinorrhoea · · ✓
SDUpper respiratory tract infection · · ✓
SROConstipation · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release